COVID-19: University of Tokyo, Avgigan intermediate / highly efficient synthetic method: Yield almost 100%
DOH allots P18-M for trials of flu drug Avigan as COVID-19 treatment
RDIF and ChemRar Launch Final Stage of Favipiravir Clinical Trial –
COVID-19: Fujifilm, AI to support corona diagnosis: CT image automatic analysis
COVID-19: Nichiiko to increase production of Futhan (nafamostat): provided to Latus Therapeutics